Tema Cardiovascular And Metabolic ETF(HRTS.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
Tema Cardiovascular And Metabolic ETF
HRTS.US
News
View More

BGI Genomics, Roche roll out diagnostic tests for Alzheimer's in China

BGI Genomics and Roche Diagnostics have launched Alzheimer's diagnostic tests in China to improve access to easier diagnosis and monitoring. BGI's blood test is being used in several cities to assess disease progression, while Roche is working on a test for pTau181 in Boao. These blood tests aim to expedite diagnosis and facilitate access to treatments, contrasting with traditional methods like spinal taps and PET scans. Both companies emphasize that their tests are not standalone diagnostic tools but can aid in early screening and reduce unnecessary investigations.

Reuters·
SZ
300676
-6.85%
US
RHHBY
+0.30%
Reuters·
SZ
300676
-6.85%
US
RHHBY
+0.30%

UnitedHealthcare to Support Rural Hospitals with Accelerated Medicare Advantage Payments, Providing Immediate Cash-Flow Relief

UnitedHealthcare has launched the Rural Payment Acceleration Pilot to support independent rural hospitals by accelerating Medicare Advantage payment timelines from less than 30 days to under 15 days. This initiative aims to provide immediate cash-flow relief and enhance the sustainability of these hospitals. CEO Bobby Hunter emphasized the importance of rural hospitals in communities and the goal of improving patient care. The pilot will inform future expansions to additional hospitals, reinforcing UnitedHealthcare's commitment to rural health stability.

Press Releases·
US
UNH
+1.19%
Press Releases·
US
UNH
+1.19%

At the "Medical Spring Festival," NVIDIA elaborated on "How to Implement AI in Healthcare"

JP Morgan stated that NVIDIA is making a "full-stack" layout in AI healthcare, building a closed loop from chips to tools to domain models, known as the "dry lab - wet lab" flywheel. At the same time, AI is transitioning from "pilot" to "employed," with the deployment speed of commercial AI in the U.S. healthcare industry being three times that of the overall economy. At the physical laboratory level, NVIDIA is collaborating with Thermo Fisher Scientific, and the industrialization process of drug discovery is also accelerating

Wallstreetcn·
US
TMO
+0.45%
US
NVDA
+2.13%
US
NVDL
+4.15%
Wallstreetcn·
US
TMO
+0.45%
US
NVDA
+2.13%
US
NVDL
+4.15%

Thermo Fisher wins contracts as pharma shifts production to US, CEO says

Thermo Fisher Scientific has secured contracts to assist pharmaceutical companies in relocating production from Europe and Asia to the U.S., according to CEO Marc Casper. This trend, driven by a focus on reshoring, is expected to gain momentum in 2027 and 2028. Casper noted that the acquisition of Sanofi's manufacturing site in New Jersey was part of this expansion strategy. He also highlighted improving biotech funding and confidence in the pharmaceutical sector's collaboration with the U.S. administration, indicating a positive outlook for the industry.

Reuters·
US
TMO
+0.45%
Reuters·
US
TMO
+0.45%

Thermo Fisher Scientific Highlights Strong 2025 Performance and Growth Strategy in New Presentation

Thermo Fisher Scientific Inc. presented its 2025 performance and growth strategy at the J.P. Morgan Healthcare Conference, reporting revenues of approximately $44 billion and an R&D investment of $1.4 billion. The company highlighted its leadership in innovative technologies and biopharma services, focusing on attractive end markets such as diagnostics and healthcare. Ongoing efforts to enhance productivity and customer engagement were also discussed. The full presentation is accessible via a provided link.

Reuters·
US
TMO
+0.45%
Reuters·
US
TMO
+0.45%
© 2026 Longbridge｜Disclaimer